Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

February 25, 2021

SDHC Methylation Pattern in Patients With Carney Triad.

Applied Immunohistochemistry & Molecular Morphology : AIMM
Magdalena DaumovaOndrej Daum
February 25, 2021
Open Access

Nodular Fasciitis With Malignant Morphology and a COL6A2-USP6 Fusion: A Case Report (of a 10-Year-old Boy).

International Journal of Surgical Pathology
Tess TomassenUta Flucke
February 25, 2021
Open Access

Chromatin dysregulation associated with NSD1 mutation in head and neck squamous cell carcinoma.

Cell Reports
Nargess FarhangdoostJacek Majewski
February 25, 2021
Review

MicroRNA signature in liver cancer.

Pathology, Research and Practice
Soudeh Ghafouri-FardMohammad Taheri
February 24, 2021
Review

Drivers of Gene Expression Dysregulation in Pancreatic Cancer.

Trends in Cancer
Swati VenkatMichael E Feigin
February 24, 2021

Depletion of H3K36me2 recapitulates epigenomic and phenotypic changes induced by the H3.3K36M oncohistone mutation.

Proceedings of the National Academy of Sciences of the United States of America
Kartik N RajagopalanChao Lu
February 24, 2021
Open Access

Network models of primary melanoma microenvironments identify key melanoma regulators underlying prognosis.

Nature Communications
Won-Min SongBin Zhang
February 24, 2021

Integrative analysis of genome-wide DNA methylation and gene expression profiles reveals important epigenetic genes related to milk production traits in dairy cattle.

Journal of Animal Breeding and Genetics = Zeitschrift Für Tierzüchtung Und Züchtungsbiologie
Wanting DongLi Jiang
February 24, 2021

Impact of RASSF1A gene methylation on clinico-pathological features of tumor and non-tumor tissue of breast cancer.

Annals of Diagnostic Pathology
Vivek GuptaPrajakta Deshpande
February 22, 2021
Review

Anticancer innovative therapy congress: Highlights from the 10th anniversary edition.

Cytokine & Growth Factor Reviews
Francesca De SantisMassimo Di Nicola
February 23, 2021
Open Access

NOL4 is Downregulated and Hyper-Methylated in Papillary Thyroid Carcinoma Suggesting Its Role as a Tumor Suppressor Gene.

International Journal of Endocrinology and Metabolism
Sara SheikholeslamiLadan Teimoori-Toolabi
February 23, 2021
Review
Open Access

Enhancing the Efficacy of Tumor Vaccines Based on Immune Evasion Mechanisms.

Frontiers in Oncology
Jianyu ChenYuhua Li
February 23, 2021
Review
Open Access

The Roles of circRNAs in Liver Cancer Immunity.

Frontiers in Oncology
Ying TangDa-Yong Zheng
February 23, 2021
Review
Open Access

Epigenetic Landscape of Liquid Biopsy in Colorectal Cancer.

Frontiers in Cell and Developmental Biology
Aitor Rodriguez-CasanovaAngel Diaz-Lagares
February 23, 2021
Open Access

HDAC inhibition prevents transgene expression downregulation and loss-of-function in T-cell-receptor-transduced T cells.

Molecular Therapy Oncolytics
Tamson V MooreMichael I Nishimura

Sign up to follow this feed and discover related papers.

Related Feeds

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.

Anthracycline Sensitivity & Chromatin (Keystone)

Anthracyclines are used in the treatment of cancer and work by inhibiting topoisomerase II (TOP2). Recent evidence suggests that because DNA accessibility is crucial for TOP2 binding, chromatin regulatory genes should predict anthracycline response. Find the latest research on anthracycline sensitivity and chromatin regulators in this feed.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics and Chemical Tools (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Using novel chemical tools allows us to learn more about these epigenetic changes and how they impact the neoplastic process. Follow this feed to learn more about cancer epigenetics and chemical tools.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

© 2021 Meta ULC. All rights reserved
/feed-previews/cancer-epigenetics-and-senescence/5947730c-0c12-4774-93cc-de874a1f59a8